Heat stroke differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 81: | Line 81: | ||
|} | |} | ||
<br>Heat stroke must be differentiated from other conditions that may cause hyperthermia. | <br>Heat stroke must be differentiated from other conditions that may cause hyperthermia. | ||
{| | <br> | ||
{| align=center | |||
|- | |- | ||
| | | | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
!style="background:#4479BA; color: #FFFFFF;" |Disease | |||
!style="background:#4479BA; color: #FFFFFF;" |Symptoms and signs | |||
!style="background:#4479BA; color: #FFFFFF;" |Labs | |||
!style="background:#4479BA; color: #FFFFFF;" |Other findings | |||
|- | |||
|align="center" style="background:#DCDCDC;"|Heat stroke | |||
|style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* CNS dysfunction ([[disorientation]], [[headache]], irrational behavior, irritability, emotional instability, [[Confusion|confusion,]] [[coma]], or [[seizure]]) | * CNS dysfunction ([[disorientation]], [[headache]], irrational behavior, irritability, emotional instability, [[Confusion|confusion,]] [[coma]], or [[seizure]]) | ||
* [[Hypotension]] and [[tachycardia]] | * [[Hypotension]] and [[tachycardia]] | ||
* [[Hyperventilation]] | * [[Hyperventilation]] | ||
* [[Weakness]], [[nausea and vomiting]], profuse sweating, [[dehydration]]. | * [[Weakness]], [[nausea and vomiting]], profuse sweating, [[dehydration]]. | ||
|Electrolyte disturbances, increased [[Creatine kinase|CK]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]] | |style="padding: 5px 5px; background: #F5F5F5;" align="left" |Electrolyte disturbances, increased [[Creatine kinase|CK]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]] | ||
|Relevant history of excessive exercise and lack of water access | |style="padding: 5px 5px; background: #F5F5F5;" align="left" |Relevant history of excessive exercise and lack of water access | ||
|- | |- | ||
|[[Neuroleptic malignant syndrome]] | |align="center" style="background:#DCDCDC;"|[[Neuroleptic malignant syndrome]] | ||
| | |style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Change in mental status | * Change in mental status | ||
* [[Muscle rigidity]] | * [[Muscle rigidity]] | ||
* Autonomic instability (labile [[BP]], [[tachypnea]], profuse sweating) | * Autonomic instability (labile [[BP]], [[tachypnea]], profuse sweating) | ||
|Electrolyte disturbances, increased [[Creatine kinase|CK]], [[Lactate dehydrogenase|LDH]], [[ALP]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]], [[leukocytosis]], [[myoglobinuria]]. | |style="padding: 5px 5px; background: #F5F5F5;" align="left" |Electrolyte disturbances, increased [[Creatine kinase|CK]], [[Lactate dehydrogenase|LDH]], [[ALP]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]], [[leukocytosis]], [[myoglobinuria]]. | ||
|Relevant history of recent use of anti-psychotics | |style="padding: 5px 5px; background: #F5F5F5;" align="left" |Relevant history of recent use of anti-psychotics | ||
|- | |- | ||
|[[Malignant hyperthermia]] | |align="center" style="background:#DCDCDC;"|[[Malignant hyperthermia]] | ||
| | |style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Masseter muscle|Masseter]] [[muscle rigidity]] (early) | * [[Masseter muscle|Masseter]] [[muscle rigidity]] (early) | ||
* Generalized muscle rigidity | * Generalized muscle rigidity | ||
* [[Sinus tachycardia]] | * [[Sinus tachycardia]] | ||
* [[Arrhythmias|Arrhythmia]] | * [[Arrhythmias|Arrhythmia]] | ||
|[[Hypercarbia]] (PaCO2) >65 mmHg, [[hyperkalemia]] | |style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hypercarbia]] (PaCO2) >65 mmHg, [[hyperkalemia]] | ||
|History of receiving anaesthetic agent | |style="padding: 5px 5px; background: #F5F5F5;" align="left" |History of receiving anaesthetic agent | ||
|- | |- | ||
|[[Serotonin syndrome]] | |align="center" style="background:#DCDCDC;"|[[Serotonin syndrome]] | ||
| | |style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Mental status changes ([[anxiety]], agitated [[delirium]], [[restlessness]], and [[disorientation]]) | * Mental status changes ([[anxiety]], agitated [[delirium]], [[restlessness]], and [[disorientation]]) | ||
* Autonomic instability ([[diaphoresis]], [[tachycardia]],, [[hypertension]], [[vomiting]], and diarrhea) | * Autonomic instability ([[diaphoresis]], [[tachycardia]],, [[hypertension]], [[vomiting]], and diarrhea) | ||
* Neuromuscular hyperactivity ([[tremor]], [[myoclonus]], [[hyperreflexia]], and bilateral [[Babinski sign]]) | * Neuromuscular hyperactivity ([[tremor]], [[myoclonus]], [[hyperreflexia]], and bilateral [[Babinski sign]]) | ||
|Elevated [[Creatine kinase|CK]], [[Lactate dehydrogenase|LDH]], [[Alkaline phosphatase|ALP]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]] | |style="padding: 5px 5px; background: #F5F5F5;" align="left" |Elevated [[Creatine kinase|CK]], [[Lactate dehydrogenase|LDH]], [[Alkaline phosphatase|ALP]], [[Aspartate transaminase|AST]], and [[Alanine transaminase|ALT]] | ||
|History of recent use of [[Selective serotonin reuptake inhibitor|SSRIs]], [[Serotonin-norepinephrine reuptake inhibitor|SNRIs]] , or [[Monoamine oxidase inhibitor|MAOIs]]. | |style="padding: 5px 5px; background: #F5F5F5;" align="left" |History of recent use of [[Selective serotonin reuptake inhibitor|SSRIs]], [[Serotonin-norepinephrine reuptake inhibitor|SNRIs]] , or [[Monoamine oxidase inhibitor|MAOIs]]. | ||
|- | |- | ||
|[[Sepsis]] | |align="center" style="background:#DCDCDC;"|[[Sepsis]] | ||
| | |style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Altered mental status ([[confusion]], altered consciousness, [[coma]], or [[seizure]]) | * Altered mental status ([[confusion]], altered consciousness, [[coma]], or [[seizure]]) | ||
* Respiratory rate ≥22/minute | * Respiratory rate ≥22/minute | ||
* Systolic blood pressure ≤100 mmHg | * Systolic blood pressure ≤100 mmHg | ||
|[[Thrombocytopenia]], [[leukocytosis]], [[leukopenia]], elevated [[Creatinine|Cr]] | |style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Thrombocytopenia]], [[leukocytosis]], [[leukopenia]], elevated [[Creatinine|Cr]] | ||
| | |style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
|} | |} | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 18:44, 24 May 2017
Heat stroke Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Heat stroke differential diagnosis On the Web |
American Roentgen Ray Society Images of Heat stroke differential diagnosis |
Risk calculators and risk factors for Heat stroke differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
Differentiating Heat stroke from other Diseases
Differentiation between 2 types of heat stroke (Classic vs Exertional) is based on history, clinical findings, and laboratory findings.
The following table summarizes their differentiating feature.
|
Heat stroke must be differentiated from other conditions that may cause hyperthermia.
References |